Direct interaction between EIF6-224aa and the oncogene MYH9 in breast cancer inhibits the ubiquitin-proteasome pathway mediated activation of the Wnt/β-catenin pathway, thereby reducing the degradation of MYH9.42 This evidence concerns the gene MYH9 and breast carcinoma.